industry

life sciences

• Market Opportunity Assessment
• Pipeline Drug Valuation
• Market Planning and Pricing
• Private Equity Due Diligence

• Rethinking Portfolio Strategies (PDF)

Our Capabilities

Dean & Company has assisted life sciences clients on a wide range of issues, including high-level strategic thinking, M&A strategy and due diligence, and key functional initiatives such as customer targeting and channel optimization. Our clients have included top global pharmaceutical companies, specialty pharmaceutical companies, major vaccine manufacturers, emerging biotech startups, and medical device companies.

BUSINESS ISSUES	HOW DEAN CAN HELP
	High-Level Strategic Thinking/M&A Strategy/Due Diligence Industry Analysis Market Size/Growth Potential Competitor Segmentation Strategic Options
	Key Functional Initiatives Pricing Strategy Financial P&L Functional Budgets Customer Targeting Programs Market Development Programs Operations Initiatives New Product Introduction Plan
	Tools and Support Segmented Profitability De-averaged Costs Metrics Definition Accountability Metrics